Table 3.

Pearson correlation matrix (95% confidence intervals) for selected outcome variables based upon changes in outcome measures from Baseline to Week 8.

	24hr Pain	Intercourse Pain	CST-Vestibule	Algesiometer	Pelvic Muscle Pain
24hr Pain	1.00	0.33* (0.15, 0.48)	0.22 (0.03, 0.39)	−0.18 (−0.36, 0.00)	−0.03 (−0.12, 0.15)
Intercourse Pain	0.33* (0.15, 0.48)	1.00	−0.01 (−0.35, 0.22)	0.00 (−0.24, 0.24)	−0.22 (−0.44, 0.01)
CST-Vestibule	0.22 (0.03, 0.39)	−0.01 (−0.35, 0.22)	1.00	−0.35* (−0.50, −0.17)	0.28* (0.10, 0.44)
Algesiometer	−0.18 (−0.36, 0.00)	0.00 (−0.24, 0.24)	−0.35* (−0.50, −0.17)	1.00	0.02 (−0.16, 0.20)
Pelvic Muscle Pain	−0.03 (−0.12, 0.15)	−0.22 (−0.44, 0.01)	0.28* (0.10, 0.44)	0.02 (−0.16, 0.20)	1.00
	SF-McGill Total	Brief Pain Inventory	Neuropathic Pain Scale
24hr Pain	0.12 (−0.06, 0.30)	0.55* (0.40, 0.66)	0.29* (0.11, 0.45)
Intercourse Pain	0.40* (0.18, 0.58)	0.38* (0.16, 0.57)	0.40* (0.17, 0.58)
CST-Vestibule	0.10 (−0.08, 0.30)	0.16 (−0.02, 0.33)	0.17 (−0.01, 0.34)
Algesiometer	0.00 (−0.19, 0.18)	−0.16 (−0.34, 0.02)	−0.16 (−0.33, 0.03)
Pelvic Muscle Pain	0.14 (−0.04, 0.32)	0.01 (−0.17, 0.19)	0.01 (−0.20, 0.17)

^*P< 0.01